Showing results (41-50 of 88) with videos related to

Sort By:
Pageof 9
International Journal of Molecular Sciences|November 26, 2022
NKp44-Derived Peptide Used in Combination Stimulates Antineoplastic Efficacy of Targeted Therapeutic DrugsMuhammed Iraqi, Priyanka Bolel, Rhitajit Sarkar, et al.
International Immunology|February 26, 2010
IL-1-induced inflammation promotes development of leishmaniasis in susceptible BALB/c miceElena Voronov, Shahar Dotan, Lubov Gayvoronsky, et al.
Cancer Research|February 7, 2007
Interleukin-1beta-driven inflammation promotes the development and invasiveness of chemical carcinogen-induced tumorsYakov Krelin, Elena Voronov, Shahar Dotan, et al.
JCI Insight|March 13, 2019
Repression of AXL expression by AP-1/JNK blockage overcomes resistance to PI3Ka therapyMai Badarni, Manu Prasad, Noa Balaban, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 30, 2021
Hydroxychloroquine synergizes with the PI3K inhibitor BKM120 to exhibit antitumor efficacy independent of autophagyXin Peng, Shaolu Zhang, Wenhui Jiao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2019
Genomic Landscape of Pancreatic Adenocarcinoma in Younger versus Older Patients: Does Age Matter?Irit Ben-Aharon, Moshe Elkabets, Raphael Pelossof, et al.
Bioengineering & Translational Medicine|September 30, 2021
Cell stiffness predicts cancer cell sensitivity to ultrasound as a selective superficial cancer therapyEden Bergman, Riki Goldbart, Tamar Traitel, et al.
European Journal of Cancer (Oxford, England : 1990)|March 15, 2006
Effects of micro-environment- and malignant cell-derived interleukin-1 in carcinogenesis, tumour invasiveness and tumour-host interactionsRon N Apte, Yakov Krelin, Xiaoping Song, et al.
Cancers|February 8, 2020
TGF-Beta-Activated Cancer-Associated Fibroblasts Limit Cetuximab Efficacy in Preclinical Models of Head and Neck CancerKsenia M Yegodayev, Ofra Novoplansky, Artemiy Golden, et al.
Science (New York, N.Y.)|March 25, 2017
PI3K pathway regulates ER-dependent transcription in breast cancer through the epigenetic regulator KMT2DEneda Toska, Hatice U Osmanbeyoglu, Pau Castel, et al.
Pageof 9